Exane Derivatives’s Stellantis STLA Stock Holding History

Exane Derivatives’s Portfolio STLA Stock Details STLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$381K	Sell	31,141 -270,625	-90%	-$3.83M	0.22%	112
2022 Q1	$4.96M	Sell	301,766 -1,359,929	-82%	-$24.9M	1.4%	9
2021 Q4	$31.4M	Buy	1,661,695 +934,941	+129%	+$18M	7.59%	1
2021 Q3	$13.9M	Sell	726,754 -724,649	-50%	-$14.3M	3.35%	2
2021 Q2	$28M	Buy	1,451,403 +526,447	+57%	+$9.9M	6.35%	1
2021 Q1	$16.4M	Sell	924,956 -353,671	-28%	-$5.95M	4.68%	1
2020 Q4	$23M	Buy	1,278,627 +685,455	+116%	+$10.1M	6.77%	1
2020 Q3	$7.3M	Buy	+593,172	New	+$6.6M	2.11%	9
2020 Q1	–	Sell	-729,277	Closed	-$8.64M	–	738
2019 Q4	$8.96M	Sell	729,277 -1,442,162	-66%	-$20.9M	1.66%	9
2019 Q3	$27.7M	Buy	2,171,439 +643,181	+42%	+$8.61M	4.96%	2
2019 Q2	$21.6M	Buy	+1,528,258	New	+$22.2M	3.78%	3
2019 Q1	–	Sell	-301,176	Closed	-$4.63M	–	708
2018 Q4	$4.37M	Sell	301,176 -531,296	-64%	-$8.56M	0.79%	25
2018 Q3	$7.34M	Buy	832,472 +533,847	+179%	+$9.43M	1.38%	13
2018 Q2	$59K	Buy	+298,625	New	+$6.54M	0.01%	378
2018 Q1	–	Sell	-502,571	Closed	-$11M	–	658
2017 Q4	$9.19M	Buy	+502,571	New	+$8.84M	1.58%	14
2017 Q3	–	Sell	-606,531	Closed	-$8.39M	–	640
2017 Q2	$5.39M	Buy	+606,531	New	+$6.45M	1.16%	14
2017 Q1	–	Sell	-96,108	Closed	-$1.03M	–	672
2016 Q4	$784K	Sell	96,108 -179,496	-65%	-$1.34M	0.15%	106
2016 Q3	$2.78M	Sell	275,604 -352,478	-56%	-$2.31M	0.42%	56
2016 Q2	$3.7M	Buy	+628,082	New	+$4.55M	0.61%	42
2016 Q1	–	Sell	-1,173,604	Closed	-$8.48M	–	613
2015 Q4	$10.8M	Sell	1,173,604 -34,310	-3%	-$322K	1.48%	30
2015 Q3	$10.2M	Buy	1,207,914 +855,041	+242%	+$8.18M	1.29%	31
2015 Q2	$3.48M	Buy	352,873 +277,309	+367%	+$2.84M	0.37%	50
2015 Q1	$807K	Buy	+75,564	New	+$706K	0.09%	108

Other funds holding STLA

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BOI

Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Exane Derivatives's STLA Position: Q2 2022 in Review

Exane Derivatives reduced its Stellantis (STLA) stake by 90% in Q2 2022, selling an estimated $3.83M and leaving 31,141 shares worth $381K. The position accounts for 0.22% of the portfolio, ranked #112.

Exane Derivatives first reported a position in STLA in Q1 2015 and has held it in 23 quarters since. The position peaked at $31.4M in Q4 2021. 334 funds tracked by Wall St. Rank hold STLA as of Q2 2022.

Exane Derivatives held 31,141 shares of Stellantis worth $381K as of Q2 2022.
Exane Derivatives sold 270,625 Stellantis shares in Q2 2022, an estimated $3.83M.
Stellantis made up 0.22% of Exane Derivatives's portfolio in Q2 2022, its #112 holding.
Exane Derivatives first reported a position in Stellantis in Q1 2015 and has held it in 23 quarters since.
Exane Derivatives's Stellantis position peaked at $31.4M in Q4 2021.
334 funds tracked by Wall St. Rank held Stellantis as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.